The Biden administration has sought to avert shortages of monoclonal antibodies this week as an analysis published Tuesday found that treating the nation’s hospitalized, unvaccinated population topped an estimated $5.7 billion.

As of Monday, the federal government has taken over distribution of monoclonal antibody treatment and has purchased 1.4 million additional doses — a move likely to reduce the medication in parts of the country with high infection rates. The new move will temporarily allow the U.S. Department of Health and Human Services to implement rules for distribution of the critical covid-19 therapy instead of permitting states, medical facilities and doctors to order them directly.

The president has expressed waning patience with country’s unvaccinated, and a new Kaiser Family Foundation analysis shows that the unimmunized is leading to billions in “preventable costs,” with projections showing that hospitalization costs nearly doubled in August the estimates for June and July combined.

Here’s what to know

  • Senior advisers in the Trump administration in February 2020 privately discussed the government’s “critical mistakes” in preparing for the coronavirus, countering optimistic claims President Donald Trump made in public, according to emails obtained by the House select subcommittee on the pandemic.
  • Sixty percent of Americans support President Biden’s vaccine requirements for federal employees and businesses with more than 100 employees, according to an Axios/Ipsos poll released Tuesday.
  • Pfizer expects to seek emergency use authorization for its coronavirus vaccine from federal regulators to immunize children ages 5-11 in early October and ages 6-months to 5 the following month, CFO Frank D’Amelio said Tuesday.